Suppr超能文献

利尿药托拉塞米的肾小管效应。

Tubular effects of the diuretic torasemide.

作者信息

Lohrmann E, Burhoff I, Greger R

机构信息

Physiologisches Institut, Albert-Ludwigs-Universität, Freiburg, Germany.

出版信息

Cardiology. 1994;84 Suppl 2:135-42. doi: 10.1159/000176466.

Abstract

Torasemide is a lipophilic loop diuretic which is largely metabolized in the liver and has an almost neutral pKa. Experiments were designed to address the questions of whether torasemide is secreted by the proximal tubule, and hence accumulates in tubular fluid, whether torasemide paralyses active transport in the cortical thick ascending limb of the nephron and hence reduces its ATP requirement, and finally whether torasemide is active in its protonated or unprotonated form. Intravenous torasemide, 10 mg/kg, induced a marked diuresis and natriuresis and a moderate kaliuresis in antidiuretic rats. All effects were dose-dependently suppressed by intravenous probenecid, 20-80 mg/kg, indicating that torasemide is secreted by the anion secretory system of the proximal tubule. A time-dependent depolarization of the basolateral membrane of in vitro perfused rabbit cortical thick ascending limb segments was observed after removal of metabolic substrates and after addition of ouabain. This effect, caused by Na+ entry, K+ loss and cell swelling, was prevented when torasemide was added to the luminal perfusate before substrate removal or addition of ouabain, indicating that torasemide significantly reduced ATP consumption of the cortical thick ascending limb. To test whether protonated or unprotonated torasemide was the biologically active compound, cortical thick ascending limb segments were perfused over the pH range 6-8 and torasemide was added in the concentration range 0.01-10 mumol/l; active transport was measured as the equivalent short-circuit current.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

托拉塞米是一种亲脂性袢利尿剂,主要在肝脏代谢,其pKa几乎呈中性。设计实验旨在解决以下问题:托拉塞米是否由近端小管分泌,从而在肾小管液中蓄积;托拉塞米是否使肾单位皮质厚壁升支的主动转运麻痹,从而降低其ATP需求;最后,托拉塞米的质子化形式还是非质子化形式具有活性。静脉注射10mg/kg托拉塞米可在抗利尿大鼠中诱导显著的利尿、利钠和中度利尿钾作用。静脉注射20 - 80mg/kg丙磺舒可剂量依赖性地抑制所有这些作用,表明托拉塞米由近端小管的阴离子分泌系统分泌。在去除代谢底物并添加哇巴因后,观察到体外灌注的兔皮质厚壁升支节段基底外侧膜出现时间依赖性去极化。这种由Na⁺内流、K⁺丢失和细胞肿胀引起的效应,在去除底物或添加哇巴因之前向管腔灌注液中加入托拉塞米时可被阻止,表明托拉塞米显著降低了皮质厚壁升支的ATP消耗。为了测试质子化或非质子化的托拉塞米是否为生物活性化合物,在pH值6 - 8范围内对皮质厚壁升支节段进行灌注,并加入浓度范围为0.01 - 10μmol/L的托拉塞米;将主动转运测量为等效短路电流。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验